| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/22/2008 | US20080118498 Appetite hormone specific immunoglobulin for prevention and treatment of eating and weight related disorders |
| 05/22/2008 | US20080118497 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH) |
| 05/22/2008 | US20080118496 Using tumor necrosis factor antibodies as therapeutic in treatment of inflammatory disorders |
| 05/22/2008 | US20080118495 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |
| 05/22/2008 | US20080118494 Transgenic lymphocyte for use as model to screen viral activating and inhibitory agenys; viricides and vaccines |
| 05/22/2008 | US20080118487 Cell growth factor polypeptide for use in enhancing muscle growth and treatment muscular disorders |
| 05/22/2008 | US20080118468 Novel Salmonella Bacteriophage and Uses Thereof |
| 05/22/2008 | US20080118466 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers |
| 05/22/2008 | US20080118464 For diagnosis, genetic engineering; post-translation modification |
| 05/22/2008 | US20080118463 Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof |
| 05/22/2008 | US20080118460 Of two biodegradable polymers, one being a homo- or copolylactone having glyceric acid as a monomer, thus having a higher density of functional groups for better small molecule drug conjugation; polymerization, drug conjugation, and purification |
| 05/22/2008 | US20080118437 Therapy for bone metastasis; antibody, antisense or siRNA inhibits expression of MCP-1; docetaxel chemotherapy agent; measure level of expression of MCP-1 relative to non-cancerous prostate tissue; determine treatment course |
| 05/22/2008 | CA2669800A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | CA2669485A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | CA2669345A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | CA2669237A1 Enterococcus faecalis and/or enterococcus faecium antigens |
| 05/22/2008 | CA2669219A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 05/22/2008 | CA2669181A1 Lingo binding molecules and pharmaceutical use thereof |
| 05/22/2008 | CA2668764A1 Novel compositions for the treatment of various inflammatory conditions |
| 05/22/2008 | CA2668693A1 Therapeutic uses of tim-3 modulators |
| 05/22/2008 | CA2668503A1 Cancerous disease modifying antibodies 180706-01 |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/22/2008 | CA2666682A1 Anti-il-13r.alpha.1 antibodies and their uses thereof |
| 05/22/2008 | CA2666679A1 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 05/22/2008 | CA2666342A1 Li-key enhanced vaccine potency |
| 05/22/2008 | CA2665808A1 Ccr2 antagonists for treatment of fibrosis |
| 05/22/2008 | CA2665239A1 Human antibodies that bind cxcr4 and uses thereof |
| 05/22/2008 | CA2654000A1 Anti-dll4 antibodies and methods using same |
| 05/22/2008 | CA2650091A1 Vaccine for avian influenza and methods of use |
| 05/22/2008 | CA2646611A1 Combinatorial therapy |
| 05/21/2008 | EP1923468A1 Lentiviral vectors for gene transfer in quiescent (G0) cells |
| 05/21/2008 | EP1923466A2 Vectors encoding recombinant AAV genomes |
| 05/21/2008 | EP1923465A1 Inhibitor protein for the WNT signal pathway |
| 05/21/2008 | EP1923399A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 05/21/2008 | EP1923072A1 Prophylactic/therapeutic agent for cancer |
| 05/21/2008 | EP1923071A1 Equine herpesvirus vaccine |
| 05/21/2008 | EP1923070A1 Vaccine for vaccinating feline against influenza virus |
| 05/21/2008 | EP1923069A1 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| 05/21/2008 | EP1922416A2 Antigens for vaccination against and detection of mycoplasma suis |
| 05/21/2008 | EP1922405A2 Genes from actinobacillus succinogenes 13oz (atcc 55618) for production of chemicals from the a. succinogenes c4-pathway |
| 05/21/2008 | EP1922338A2 Polyclonal antiserum against a universal tumor antigen |
| 05/21/2008 | EP1922337A2 Trail receptor 2 polypeptides and antibodies |
| 05/21/2008 | EP1922335A2 Tumor-associated peptides binding promiscuously to human leukocyte antigen (hla) class ii molecules |
| 05/21/2008 | EP1922334A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/21/2008 | EP1922332A2 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 05/21/2008 | EP1922085A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 05/21/2008 | EP1922083A2 Truncated memapsin 2 for use for treating alzheimer's disease |
| 05/21/2008 | EP1922077A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 05/21/2008 | EP1752163A4 Agent for actively restoring structure and functions of damaged tissues and organs |
| 05/21/2008 | EP1682578B1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/21/2008 | EP1482981B1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/21/2008 | EP1467753B1 Recombinant herpesvirus of turkeys and use thereof |
| 05/21/2008 | EP1366158B1 Trp8 markers for cancer |
| 05/21/2008 | EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP1161262B1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 05/21/2008 | EP1150714B1 Methods for inhibiting brain tumor growth |
| 05/21/2008 | EP1144001B1 Inactivated influenza virus vaccine for nasal or oral administration |
| 05/21/2008 | EP1096952B1 Polysaccharide vaccine for staphylococcal infections |
| 05/21/2008 | EP1064005B1 Urokinase plasminogen activator receptor as a target for diagnosis of micrometastases |
| 05/21/2008 | EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 05/21/2008 | EP1007688B1 Desaturase antigen of mycobacterium tuberculosis |
| 05/21/2008 | EP1004315B1 Preventives and/or remedies containing anti-il-6 receptor neutralizing antibodies for reducing the excretion of urinary protein in systemic lupus erythematosus |
| 05/21/2008 | EP0904395B1 Herpes simplex virus strains |
| 05/21/2008 | EP0807166B1 A method of preparing an undifferentiated cell |
| 05/21/2008 | EP0752887B1 Immunodeficiency recombinant poxvirus |
| 05/21/2008 | CN101184778A P-cadherin antibodies |
| 05/21/2008 | CN101184776A Novel anti-plgf antibody |
| 05/21/2008 | CN101184507A Treatment of inflammatory bowel disease (ibd) |
| 05/21/2008 | CN101184506A Methods and compositions for modulating hyperstabilized c-met |
| 05/21/2008 | CN101184505A Soluble immunoregulatory factor |
| 05/21/2008 | CN101184504A Vaccines against chlamydial infection |
| 05/21/2008 | CN101184503A Combination vaccines with whole cell pertussis antigen |
| 05/21/2008 | CN101184502A Polypeptides |
| 05/21/2008 | CN101184501A Novel vaccine formulations |
| 05/21/2008 | CN101184500A Coccidial vaccine and methods of making and using same |
| 05/21/2008 | CN101184499A Intranasal administration of active agents to the central nervous system |
| 05/21/2008 | CN101182529A Fusion gene and genetic engineering bacterium, and preparation and applications thereof |
| 05/21/2008 | CN101182516A Bacterium surface displaying novel system, method and applications |
| 05/21/2008 | CN101181637A Method for producing swine fever live vaccine with cell line |
| 05/21/2008 | CN101181636A Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof |
| 05/21/2008 | CN101181635A Method for preparing pathogenicity hydrosphere unit cell bacterium killed vaccine |
| 05/21/2008 | CN101181269A Methods of treating cancer using an fpt inhibitor and antineoplastic agents |
| 05/21/2008 | CN101181240A Technique for concentrating chicken ND-IB-AI-EDS tetrad oil emulsion killed vaccine antigen |
| 05/21/2008 | CN100389198C Streptococcal C5a peptidase vaccine |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389193C Method for safe continuous enclosed cell culture, virus production/ inactivation |
| 05/21/2008 | CN100389192C Substances for preventing and treating autoimmune diseases |
| 05/21/2008 | CN100389128C Fusion protein of single antibody-interleukin 2, its preparation and use |
| 05/21/2008 | CN100389127C I (mycobacterium tuberculosis) superoxide dismutase |
| 05/21/2008 | CN100388953C Composite mucosa immunoadjuvant for oral vaccine |
| 05/21/2008 | CN100388952C Chain coccus recombination subunit vaccine and preparation method thereof |
| 05/20/2008 | US7375206 Brother of the regulator of imprinted sites (BORIS) |
| 05/20/2008 | US7375194 For therapy of Huntington's disease |
| 05/20/2008 | US7375117 Polypeptides |
| 05/20/2008 | US7375091 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal. |
| 05/20/2008 | US7375086 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases; Nucleotide sequences coding protein for use in the treatment of crohn's disease |
| 05/20/2008 | US7375076 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein |